Fisher & Paykel Healthcare
(ASX:FPH) has reported that its full-year net profit (after tax) rose 15% to $NZ436 million last financial year.
The medical device manufacturer also says it earned a record operating revenue of $NZ815.5 (which is up 14%).
Fisher & Paykel has also increased its final dividend by 25%. It will pay 10 cents per share, plus 3.89 cents imputation credit for NZ residents. For non-residents, they will get a supplementary dividend of 1.76 cents per share.
As for outlook, the company will be launching a wide range of respiratory products in FY17 (with some used to treat sleep apnoea). The company also plans to spend NZ$200 million over the next 4-5 years and construct another building at its Auckland campus.